Correlation between c-Jun and human papillomavirus in oral premalignant and malignant lesions.
c-Jun, one of the components of the transcription factor activating protein-1 (AP-1), is suggested as a factor in malignant progression of oral lesions. c-Jun and other AP-1 components relationships with human papillomavirus (HPV) infection have been investigated, but not yet focusing on oral carcinogenesis. The aim of this study was to verify whether c-Jun immunohistochemical expression is related to HPV DNA detection in oral premalignant and malignant lesions. Fifty cases diagnosed as oral leukoplakias, with different degrees of epithelial dysplasia, and as oral squamous cell carcinomas (OSCC) were submitted to immunohistochemistry to detect c-Jun and to in situ hybridization with signal amplification to assess HPV DNA. It was verified that c-Jun nuclear expression increased according to the degree of dysplasia within the lesion, with the greatest expression in OSCC. The same did not happen concerning HPV infection--a discrete proportional relation was observed in indexes found in leukoplakia with no dysplasia, leukoplakia with dysplasia and OSCC, but statistically insignificant. When separating the group of leukoplakia by degrees of dysplasia, this relation of proportion was not observed. Nevertheless, the overall prevalence of HPV infection was 24% and the high-risk HPV types were the most frequently identified, which does not allow excluding HPV as a risk factor in oral carcinogenesis. When relating c-Jun expression and HPV infection, no statistically significant relationship is observed. Results suggest then that malignant progression mediated by c-Jun is independent of the presence of HPV in oral carcinogenesis.
Acay
Renata Rodrigues
RR
Oral Pathology Department, School of Dentistry, University of São Paulo, Avenida Prof. Lineu Prestes 2227, São Paulo, SP, Brazil.
dos Santos
Elisa
E
de Sousa
Suzana Orsini Machado
SO
D002294:Carcinoma, Squamous Cell / Q000378:metabolism / Q000821:virology*; D004279:DNA, Viral / Q000378:metabolism*; D005260:Female; D052163:Human papillomavirus 6 / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism; D006801:Humans; D007972:Leukoplakia, Oral / Q000378:metabolism / Q000821:virology; D008297:Male; D009062:Mouth Neoplasms / Q000378:metabolism / Q000821:virology*; D030361:Papillomavirus Infections / Q000378:metabolism / Q000821:virology*; D011230:Precancerous Conditions / Q000378:metabolism / Q000821:virology*; D016755:Proto-Oncogene Proteins c-jun / Q000378:metabolism*
D004279:DNA, Viral; D016755:Proto-Oncogene Proteins c-jun